CNS Pharmaceuticals, Inc. CNSP

Set alert

Price alert · CNSP

All alert types
5.00 USD +0.23 +4.82%

At close · Oct 30

5.00 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
5.00 × 1
Ask
5.10 × 10
4.25 Day range 5.00
2.13 52-week range 7.84
YTD
-4.76%
1 year
-33.42%
Open
4.60
Prev close
4.77
Mkt cap
7.31M
Vol
52.92K
Avg vol
8.37K
EPS
-17.90
P/E
0.00
Div yield
0.00%
More statistics
Low
4.25
High
5.00
Forward P/E
-0.28
Beta
1.05
Short ratio
0.04
Inst. own
0.79%
Dividend
0.00
Ex-div date
50-d avg
0.11872
200-d avg
4.42
1y target
0.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CNSP has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-7.22 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -0.1×
FY 2017: -343×FY 2018: -10.2×FY 2019: -16.8×FY 2020: -3.1×FY 2021: -1.3×FY 2022: -0.2×FY 2023: -0.3×FY 2024: -0.2×FY 2025: -0.1×
FY 2017 5y median -0.2× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 0.5×
FY 2017: -1265×FY 2018: -135×FY 2019: 8.4×FY 2020: 2.1×FY 2021: 2.8×FY 2022: 0.4×FY 2023: -1.1×FY 2024: 0.4×FY 2025: 0.5×
FY 2017 5y median 0.4× FY 2025
P/FCF -0.2×
FY 2017: -660×FY 2018: -103×FY 2019: -17.9×FY 2020: -3.9×FY 2021: -1.4×FY 2022: -0.3×FY 2023: -0.3×FY 2024: -0.1×FY 2025: -0.2×
FY 2017 5y median -0.3× FY 2025
EV/EBITDA 0.3×
FY 2017: -144×FY 2018: -11.5×FY 2019: -14.8×FY 2020: -1.6×FY 2021: -0.9×FY 2022: 0.4×FY 2023: -0.2×FY 2024: 0.3×FY 2025: 0.3×
FY 2017 5y median 0.3× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -594.1%
FY 2017: -0.2%FY 2018: -1.0%FY 2019: -5.6%FY 2020: -25.4%FY 2021: -73.9%FY 2022: -326.0%FY 2023: -294.6%FY 2024: -743.9%FY 2025: -594.1%
FY 2017 5y median -326.0% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -350.5%
FY 2017: 899.5%FY 2018: 1345.7%FY 2019: -51.0%FY 2020: -67.8%FY 2021: -218.9%FY 2022: -187.8%FY 2023: 425.3%FY 2024: -240.5%FY 2025: -350.5%
FY 2017 5y median -218.9% FY 2025
ROIC -329.5%
FY 2017: -815.7%FY 2018: 379.5%FY 2019: -50.4%FY 2020: -65.7%FY 2021: -206.7%FY 2022: -174.8%FY 2023: 456.6%FY 2024: -229.2%FY 2025: -329.5%
FY 2017 5y median -206.7% FY 2025
ROA -183.8%
FY 2017: -324.6%FY 2018: -1081.7%FY 2019: -49.0%FY 2020: -59.7%FY 2021: -165.5%FY 2022: -117.0%FY 2023: -1108.3%FY 2024: -170.8%FY 2025: -183.8%
FY 2017 5y median -170.8% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -7.3%
FY 2017: 0.0%FY 2018: -70.8%FY 2019: -334.7%FY 2020: -146.7%FY 2021: -53.2%FY 2022: -3.1%FY 2023: -26.3%FY 2024: 21.0%FY 2025: -7.3%
FY 2017 FY 2025
EPS (diluted) 92.3%
FY 2017: 0.0%FY 2018: -3271.0%FY 2019: 47.5%FY 2020: -141.5%FY 2021: 3.4%FY 2022: 32.0%FY 2023: 55.4%FY 2024: 99.7%FY 2025: 92.3%
FY 2017 FY 2025
Free Cash Flow 19.2%
FY 2017: 0.0%FY 2018: -538.5%FY 2019: -398.8%FY 2020: -105.3%FY 2021: -84.6%FY 2022: 22.0%FY 2023: -33.9%FY 2024: -21.0%FY 2025: 19.2%
FY 2017 FY 2025

Financial Health

Current Ratio 2.0×
FY 2017: 0.7×FY 2018: 0.5×FY 2019: 25.4×FY 2020: 8.1×FY 2021: 3.5×FY 2022: 2.6×FY 2023: 0.3×FY 2024: 3.4×FY 2025: 2.0×
FY 2017 5y median 2.6× FY 2025
Quick Ratio 2.0×
FY 2017: 0.7×FY 2018: 0.5×FY 2019: 25.4×FY 2020: 8.1×FY 2021: 3.5×FY 2022: 2.6×FY 2023: 0.3×FY 2024: 3.4×FY 2025: 2.0×
FY 2017 5y median 2.6× FY 2025
Debt / Equity 0.1×
FY 2017: -2.1×FY 2018: -0.6×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: -0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2017 5y median 0.1× FY 2025
Net Debt / EBITDA 0.4×
FY 2017: -0.0×FY 2018: -0.0×FY 2019: 1.9×FY 2020: 1.4×FY 2021: 0.3×FY 2022: 0.6×FY 2023: 0.0×FY 2024: 0.4×FY 2025: 0.4×
FY 2017 5y median 0.4× FY 2025
Interest Coverage -1050×
FY 2017: -121×FY 2018: -18.9×FY 2019: -86.7×FY 2020: -2897×FY 2021: -1560×FY 2022: -2125×FY 2023: -1367×FY 2024: -924×FY 2025: -1050×
FY 2017 5y median -1367× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31